Trial intelligence / Profile preview

MAMI Methoxyflurane as Analgesic in Prehospital Acute Myocardial Infarction

2023-507296-21-00Phase 3Withdrawn

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2025
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in myocardial infarction (MI) comparing Methoxyflurane (Penthrox) with Morphine (2 arms). Planned start Jun 2025; status: withdrawn.

02

Drugs

methoxyfluranemorphine
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2023-507296-21-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-507296-21-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call